3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
11
Neoplasm Metastasis
7
Neoplasms
5
Carcinoma, Renal Cell
3
Tuberous Sclerosis
2
Triple Negative Breast Neoplasms
2
Recurrence
2
Prostatic Neoplasms
2
Neuroendocrine Tumors
2
Leukemia, Myeloid, Acute
2
Gastrointestinal Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Neuroendocrine
2
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Sarcoma
1
Renal Cell Cancer Metastatic
1
Relapsed Pediatric Solid Tumor
1
Ovarian Neoplasms
1
Osteosarcoma
1
Nasopharyngeal Carcinoma
1
Metatropic dwarfism
1
Melanoma
1
Lymphoma
1
Liver Neoplasms
1
Liver Failure
1
Liver Diseases
1
Liver Cirrhosis
1
Leukemia, Myelomonocytic, Acute
1
Interventions
Population Groups
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Intellectual Disability
×
Everolimus
×
Clear all
NCT01730209
2015-05-05
RAPIT
Erasmus Medical Center
Phase 2/3
Unknown
60 enrolled